{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:37:39Z","timestamp":1790422659164,"version":"4.1.0"},"reference-count":71,"publisher":"BMJ","issue":"12","funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["Project Grant APP1062638"],"award-info":[{"award-number":["Project Grant APP1062638"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2016,11,14]]},"published-print":{"date-parts":[[2016,12]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Systemic sclerosis (SSc) is a severe and costly multiorgan autoimmune connective tissue disease characterised by vasculopathy and fibrosis. One of the major causes of SSc-related death is pulmonary arterial hypertension (PAH), which develops in 12\u201315% of patients with SSc and accounts for 30\u201340% of deaths. In situ thrombosis in the small calibre peripheral pulmonary vessels resulting from endothelial dysfunction and an imbalance of anticoagulant and prothrombotic mediators has been implicated in the complex pathophysiology of SSc-related PAH (SSc-PAH), with international clinical guidelines recommending the use of anticoagulants for some types of PAH, such as idiopathic PAH. However, anticoagulation has not become part of standard clinical care for patients with SSc-PAH as only observational evidence exists to support its use. Therefore, we present the rationale and methodology of a phase III randomised controlled trial (RCT) to evaluate the efficacy, safety and cost-effectiveness of anticoagulation in SSc-PAH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This Australian multicentre RCT will compare 2.5\u2005mg apixaban with placebo, in parallel treatment groups randomised in a 1:1 ratio, both administered twice daily for 3\u2005years as adjunct therapy to stable oral PAH therapy. The composite primary outcome measure will be the time to death or clinical worsening of PAH. Secondary outcomes will include functional capacity, health-related quality of life measures and adverse events. A cost-effectiveness analysis of anticoagulation versus placebo will also be undertaken.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Ethical approval for this RCT has been granted by the Human Research Ethics Committees of all participating centres. An independent data safety monitoring board will review safety and tolerability data for the duration of the trial. The findings of this RCT are to be published in open access journals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=366065&amp;isReview=true\" ext-link-type=\"uri\">ACTRN12614000418673<\/jats:ext-link>\n                      , Pre-results.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2016-011028","type":"journal-article","created":{"date-parts":[[2016,12,8]],"date-time":"2016-12-08T22:15:20Z","timestamp":1481235320000},"page":"e011028","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":17,"title":["Multicentre randomised placebo-controlled trial of oral anticoagulation with apixaban in systemic sclerosis-related pulmonary arterial hypertension: the SPHInX study protocol"],"prefix":"10.1136","volume":"6","author":[{"given":"Alicia","family":"Calderone","sequence":"first","affiliation":[{"name":"Department of Rheumatology, St Vincent's Hospital Melbourne, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Stevens","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, St Vincent's Hospital Melbourne, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Prior","sequence":"additional","affiliation":[{"name":"Department of Cardiology, St Vincent's Hospital Melbourne, Melbourne, Victoria, Australia"},{"name":"The University of Melbourne Department of Medicine at St Vincent's Hospital Melbourne, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harshal","family":"Nandurkar","sequence":"additional","affiliation":[{"name":"The University of Melbourne Department of Medicine at St Vincent's Hospital Melbourne, Melbourne, Victoria, Australia"},{"name":"Australian Centre for Blood Diseases, Central Clinical School, Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli","family":"Gabbay","sequence":"additional","affiliation":[{"name":"The University of Notre Dame, Fremantle, Western Australia, Australia"},{"name":"Institute for Respiratory Health, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna M","family":"Proudman","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Royal Adelaide Hospital, North Terrace, Adelaide, South Australia, Australia"},{"name":"University of Adelaide Discipline of Medicine at Royal Adelaide Hospital, North Terrace, Adelaide, South Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Williams","sequence":"additional","affiliation":[{"name":"Department of Allergy, Immunology and Respiratory Medicine, Alfred Hospital, Monash University, Prahran, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Celermajer","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Sahhar","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Monash Health and Monash University, Clayton, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter K K","family":"Wong","sequence":"additional","affiliation":[{"name":"Mid-North Coast Arthritis Clinic, Coffs Harbour, New South Wales, Australia"},{"name":"Faculty of Medicine, Rural Clinical School, University of New South Wales, Coffs Harbour, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Thakkar","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Liverpool Hospital, Liverpool, New South Wales, Australia"},{"name":"School of Medicine, University of Western Sydney, Penrith, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Dwyer","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Royal Hobart Hospital, Hobart, Tasmania, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Wrobel","sequence":"additional","affiliation":[{"name":"Advanced Lung Disease Unit, Fiona Stanley Hospital, Murdoch, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weng","family":"Chin","sequence":"additional","affiliation":[{"name":"Institute for Respiratory Health, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Liew","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, The Alfred Centre, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Staples","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, The Alfred Centre, Melbourne, Victoria, Australia"},{"name":"Monash Department of Clinical Epidemiology, Cabrini Institute, Cabrini Health, Suite 41 Cabrini Medical Centre, Malvern, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachelle","family":"Buchbinder","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, The Alfred Centre, Melbourne, Victoria, Australia"},{"name":"Monash Department of Clinical Epidemiology, Cabrini Institute, Cabrini Health, Suite 41 Cabrini Medical Centre, Malvern, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandana","family":"Nikpour","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, St Vincent's Hospital Melbourne, Melbourne, Victoria, Australia"},{"name":"The University of Melbourne Department of Medicine at St Vincent's Hospital Melbourne, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2016,12,8]]},"reference":[{"key":"2025120523491668000_6.12.e011028.1","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-009-8193-3"},{"key":"2025120523491668000_6.12.e011028.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2010.10.007"},{"key":"2025120523491668000_6.12.e011028.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2007.05.003"},{"key":"2025120523491668000_6.12.e011028.4","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq165"},{"key":"2025120523491668000_6.12.e011028.5","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.080281"},{"key":"2025120523491668000_6.12.e011028.6","doi-asserted-by":"publisher","DOI":"10.1002\/art.24086"},{"key":"2025120523491668000_6.12.e011028.7","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/acr.22167","article-title":"Social economic costs and health-related quality of life in patients with systemic sclerosis in Spain","volume":"66","author":"L\u00f3pez-Bastida","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025120523491668000_6.12.e011028.8","doi-asserted-by":"publisher","DOI":"10.1002\/art.30277"},{"key":"2025120523491668000_6.12.e011028.9","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.114264"},{"key":"2025120523491668000_6.12.e011028.10","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.066068"},{"key":"2025120523491668000_6.12.e011028.11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/BOR.0000000000000027","article-title":"Mortality in systemic sclerosis: lessons learned from population-based and observational cohort studies","volume":"26","author":"Nikpour","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"2025120523491668000_6.12.e011028.12","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker357"},{"key":"2025120523491668000_6.12.e011028.13","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker269"},{"key":"2025120523491668000_6.12.e011028.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.02.029"},{"key":"2025120523491668000_6.12.e011028.15","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep107"},{"key":"2025120523491668000_6.12.e011028.16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1742-1241.2010.02525.x","article-title":"How has epoprostenol changed the outcome for patients with pulmonary arterial hypertension?","volume":"168","author":"Barst","year":"2010","journal-title":"Int J Clin Pract Suppl"},{"key":"2025120523491668000_6.12.e011028.17","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/35.10.989"},{"key":"2025120523491668000_6.12.e011028.18","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq152"},{"key":"2025120523491668000_6.12.e011028.19","doi-asserted-by":"publisher","DOI":"10.1186\/ar4051"},{"key":"2025120523491668000_6.12.e011028.20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.2010.02403.x"},{"key":"2025120523491668000_6.12.e011028.21","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200806-953OC"},{"key":"2025120523491668000_6.12.e011028.22","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-0260"},{"key":"2025120523491668000_6.12.e011028.23","doi-asserted-by":"publisher","DOI":"10.1378\/chest.130.2.545"},{"key":"2025120523491668000_6.12.e011028.24","first-page":"376","article-title":"Coagulation and anticoagulation in pulmonary arterial hypertension","volume":"11","author":"Berger","year":"2009","journal-title":"Isr Med Assoc J"},{"key":"2025120523491668000_6.12.e011028.25","doi-asserted-by":"publisher","DOI":"10.1378\/chest.77.5.614"},{"key":"2025120523491668000_6.12.e011028.26","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/imj.12111","article-title":"Should patients with systemic sclerosis-related pulmonary arterial hypertension be anticoagulated?","volume":"43","author":"Nikpour","year":"2013","journal-title":"Intern Med J"},{"key":"2025120523491668000_6.12.e011028.27","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.06.00015206"},{"key":"2025120523491668000_6.12.e011028.28","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110765"},{"key":"2025120523491668000_6.12.e011028.29","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.018435"},{"key":"2025120523491668000_6.12.e011028.30","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.004526"},{"key":"2025120523491668000_6.12.e011028.31","first-page":"879","article-title":"Oral anticoagulation for pulmonary arterial hypertension: systematic review and meta-analysis","volume":"30","author":"Caldeira","year":"2014","journal-title":"Can J Cardiol"},{"key":"2025120523491668000_6.12.e011028.32","doi-asserted-by":"publisher","DOI":"10.1378\/chest.06-2674"},{"key":"2025120523491668000_6.12.e011028.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.04.017"},{"key":"2025120523491668000_6.12.e011028.34","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.096677"},{"key":"2025120523491668000_6.12.e011028.35","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehp297"},{"key":"2025120523491668000_6.12.e011028.36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11926-011-0226-2","article-title":"An update on the evaluation and management of pulmonary hypertension in scleroderma","volume":"14","author":"Coghlan","year":"2012","journal-title":"Curr Rheumatol Rep"},{"key":"2025120523491668000_6.12.e011028.37","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.100632"},{"key":"2025120523491668000_6.12.e011028.38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe1012149"},{"key":"2025120523491668000_6.12.e011028.39","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-011-0561-1"},{"key":"2025120523491668000_6.12.e011028.40","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1471-4892(01)00033-9","article-title":"Non-hemostatic activity of coagulation factor Xa: potential implications for various diseases","volume":"1","author":"Leadley","year":"2001","journal-title":"Curr Opin Pharmacol"},{"key":"2025120523491668000_6.12.e011028.41","doi-asserted-by":"publisher","DOI":"10.1160\/TH10-02-0097"},{"key":"2025120523491668000_6.12.e011028.42","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00057010"},{"key":"2025120523491668000_6.12.e011028.43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2008.03739.x"},{"key":"2025120523491668000_6.12.e011028.44","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker463"},{"key":"2025120523491668000_6.12.e011028.45","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1006885"},{"key":"2025120523491668000_6.12.e011028.46","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)62125-5"},{"key":"2025120523491668000_6.12.e011028.47","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1107039"},{"key":"2025120523491668000_6.12.e011028.48","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1007432"},{"key":"2025120523491668000_6.12.e011028.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.01.004"},{"key":"2025120523491668000_6.12.e011028.50","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01204.x"},{"key":"2025120523491668000_6.12.e011028.51","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1105819"},{"key":"2025120523491668000_6.12.e011028.52","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1207541"},{"key":"2025120523491668000_6.12.e011028.53","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.832139"},{"key":"2025120523491668000_6.12.e011028.54","doi-asserted-by":"publisher","DOI":"10.1002\/art.38098"},{"key":"2025120523491668000_6.12.e011028.55","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.166.1.at1102"},{"key":"2025120523491668000_6.12.e011028.56","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-199206000-00002"},{"key":"2025120523491668000_6.12.e011028.57","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780230202"},{"key":"2025120523491668000_6.12.e011028.58","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780401110"},{"key":"2025120523491668000_6.12.e011028.59","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-005-3513-4"},{"key":"2025120523491668000_6.12.e011028.60","doi-asserted-by":"publisher","DOI":"10.1186\/ar3876"},{"key":"2025120523491668000_6.12.e011028.61","doi-asserted-by":"crossref","first-page":"R193","DOI":"10.1186\/ar4383","article-title":"The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study","volume":"15","author":"Thakkar","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"2025120523491668000_6.12.e011028.62","doi-asserted-by":"publisher","DOI":"10.1586\/ehm.13.11"},{"key":"2025120523491668000_6.12.e011028.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.04.007"},{"key":"2025120523491668000_6.12.e011028.64","doi-asserted-by":"publisher","DOI":"10.1002\/art.23718"},{"key":"2025120523491668000_6.12.e011028.65","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(81)90007-2"},{"key":"2025120523491668000_6.12.e011028.66","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2005.069484"},{"key":"2025120523491668000_6.12.e011028.67","doi-asserted-by":"crossref","unstructured":"Lever R , Page CP . Non-anticoagulant effects of heparin: an overview. Handb Exp Pharmacol 2012;207:281\u2013305. doi:10.1007\/978-3-642-23056-1_12","DOI":"10.1007\/978-3-642-23056-1_12"},{"key":"2025120523491668000_6.12.e011028.68","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1300615"},{"key":"2025120523491668000_6.12.e011028.69","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1185\/030079905X75104","article-title":"Cost-minimization analysis of treprostinil vs. epoprostenol as an alternate to oral therapy non-responders for the treatment of pulmonary arterial hypertension","volume":"21","author":"Narine","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"2025120523491668000_6.12.e011028.70","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF03256141","article-title":"Oral therapies for the treatment of pulmonary arterial hypertension: a population-based cost-minimization analysis","volume":"7","author":"Dranitsaris","year":"2009","journal-title":"Appl Health Econ Health Policy"},{"key":"2025120523491668000_6.12.e011028.71","unstructured":"Choosing interventions that are cost-effective. Geneva: World Health Organization, 2014. http:\/\/www.who.int\/choice\/en\/ (accessed November 2016)"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2016-011028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T07:49:27Z","timestamp":1765007367000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2016-011028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":71,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2016,12,8]]},"published-print":{"date-parts":[[2016,12]]}},"alternative-id":["10.1136\/bmjopen-2016-011028"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2016-011028","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12]]}}}